TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4,31
arrow_downward
-0,92%(-0,040) 1D
US$ 4,31
0,00% (0,00)
bedtimeNa sluitingstijd
Gesloten: 20 nov, 16:00:01 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 4,31
Hoog
US$ 4,43
Laag
US$ 4,17
Beursw.
282,56 mln.
Gem. vol.
288,65K
Volume
232,76K
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 4,31
Hoog
US$ 4,43
Laag
US$ 4,17
Beursw.
282,56 mln.
Gem. vol.
288,65K
Volume
232,76K
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
AP News
·
14 uur geleden
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
4 uur geleden
25 S&P 500 Stocks Just Made New 52-Week Lows
Beinsure
·
3 uur geleden
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Yahoo Finance
·
16 uur geleden
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc